SI-BONE, Inc.

NasdaqGM:SIBN Stock Report

Market Cap: US$576.4m

SI-BONE Management

Management criteria checks 2/4

SI-BONE's CEO is Laura Francis, appointed in Apr 2021, has a tenure of 4.92 years. total yearly compensation is $7.09M, comprised of 9.2% salary and 90.8% bonuses, including company stock and options. directly owns 1.09% of the company’s shares, worth $6.28M. The average tenure of the management team and the board of directors is 4.9 years and 15.3 years respectively.

Key information

Laura Francis

Chief executive officer

US$7.1m

Total compensation

CEO salary percentage9.20%
CEO tenure4.9yrs
CEO ownership1.1%
Management average tenure4.9yrs
Board average tenure15.3yrs

Recent management updates

Recent updates

Earnings Update: SI-BONE, Inc. (NASDAQ:SIBN) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Nov 13
Earnings Update: SI-BONE, Inc. (NASDAQ:SIBN) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts

Getting In Cheap On SI-BONE, Inc. (NASDAQ:SIBN) Might Be Difficult

Nov 12
Getting In Cheap On SI-BONE, Inc. (NASDAQ:SIBN) Might Be Difficult

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Jun 26
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Earnings Update: SI-BONE, Inc. (NASDAQ:SIBN) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

May 09
Earnings Update: SI-BONE, Inc. (NASDAQ:SIBN) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts

Revenues Tell The Story For SI-BONE, Inc. (NASDAQ:SIBN) As Its Stock Soars 30%

May 08
Revenues Tell The Story For SI-BONE, Inc. (NASDAQ:SIBN) As Its Stock Soars 30%

SI-BONE (NASDAQ:SIBN) Has Debt But No Earnings; Should You Worry?

Mar 27
SI-BONE (NASDAQ:SIBN) Has Debt But No Earnings; Should You Worry?
User avatar

TORQ And TNT Will Expand Market Reach In 2025

Strong product launches and a robust innovation pipeline suggest promising future revenue growth and strengthened market positioning.

SI-BONE, Inc. (NASDAQ:SIBN) Looks Just Right With A 26% Price Jump

Jan 19
SI-BONE, Inc. (NASDAQ:SIBN) Looks Just Right With A 26% Price Jump

Market Cool On SI-BONE, Inc.'s (NASDAQ:SIBN) Revenues

Nov 04
Market Cool On SI-BONE, Inc.'s (NASDAQ:SIBN) Revenues

Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Sep 25
Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

SI-BONE, Inc.'s (NASDAQ:SIBN) P/S Is On The Mark

Apr 01
SI-BONE, Inc.'s (NASDAQ:SIBN) P/S Is On The Mark

Analyst Estimates: Here's What Brokers Think Of SI-BONE, Inc. (NASDAQ:SIBN) After Its Full-Year Report

Feb 29
Analyst Estimates: Here's What Brokers Think Of SI-BONE, Inc. (NASDAQ:SIBN) After Its Full-Year Report

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Feb 28
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Nov 12
Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Aug 09
Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Is SI-BONE (NASDAQ:SIBN) A Risky Investment?

Apr 20
Is SI-BONE (NASDAQ:SIBN) A Risky Investment?

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Jan 01
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Sep 24
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

CEO Compensation Analysis

How has Laura Francis's remuneration changed compared to SI-BONE's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025n/an/a

-US$19m

Sep 30 2025n/an/a

-US$22m

Jun 30 2025n/an/a

-US$24m

Mar 31 2025n/an/a

-US$27m

Dec 31 2024US$7mUS$652k

-US$31m

Sep 30 2024n/an/a

-US$37m

Jun 30 2024n/an/a

-US$41m

Mar 31 2024n/an/a

-US$43m

Dec 31 2023US$4mUS$622k

-US$43m

Sep 30 2023n/an/a

-US$44m

Jun 30 2023n/an/a

-US$48m

Mar 31 2023n/an/a

-US$55m

Dec 31 2022US$5mUS$604k

-US$61m

Sep 30 2022n/an/a

-US$65m

Jun 30 2022n/an/a

-US$66m

Mar 31 2022n/an/a

-US$62m

Dec 31 2021US$3mUS$527k

-US$57m

Sep 30 2021n/an/a

-US$51m

Jun 30 2021n/an/a

-US$45m

Mar 31 2021n/an/a

-US$43m

Dec 31 2020US$2mUS$386k

-US$44m

Sep 30 2020n/an/a

-US$44m

Jun 30 2020n/an/a

-US$46m

Mar 31 2020n/an/a

-US$42m

Dec 31 2019US$2mUS$375k

-US$38m

Compensation vs Market: Laura's total compensation ($USD7.09M) is above average for companies of similar size in the US market ($USD2.31M).

Compensation vs Earnings: Laura's compensation has increased whilst the company is unprofitable.

CEO

Laura Francis (58 yo)

4.9yrs
Tenure
US$7,087,404
Compensation

Ms. Laura A. Francis, MBA, has been an Independent Director of Bruker Corporation since February 18, 2025. She serves as Director at Galvanize Therapeutics, Inc. from November 2025. She serves as Chief Exe...

Leadership Team

NamePositionTenureCompensationOwnership
Jeffrey Dunn
Executive Chairman17.9yrsUS$199.71k0.18%
$ 1.1m
Laura Francis
CEO & Director4.9yrsUS$7.09m1.09%
$ 6.3m
Anshul Maheshwari
COO & CFO4.9yrsUS$2.47m0.15%
$ 864.3k
Anthony Recupero
Advisor9.7yrsUS$2.56m0.36%
$ 2.1m
Scott Yerby
Senior VP of Engineering & CTOno datano datano data
Saqib Iqbal
Vice President of Financial Planning & Analysis and Investor Relationsno datano datano data
Michael Pisetsky
Chief Business & Legal Affairs Officer9.6yrsno data0.29%
$ 1.7m
Aimee Einstein
Vice President of People & Culture4.2yrsno datano data
Daniel Cher
Senior Vice President of Clinical4.8yrsno datano data
W. Reckling
Chief Medical Officer & VP of Medical Affairsno datano datano data
Nikolas Kerr
Chief Commercial Officer4.9yrsno datano data
Jeffrey Zigler
Senior Vice President of Market Access & Reimbursementless than a yearno datano data
4.9yrs
Average Tenure
58yo
Average Age

Experienced Management: SIBN's management team is considered experienced (4.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jeffrey Dunn
Executive Chairman17.9yrsUS$199.71k0.18%
$ 1.1m
Laura Francis
CEO & Director4.9yrsUS$7.09m1.09%
$ 6.3m
Timothy Davis
Lead Independent Director17.9yrsUS$184.71k0.12%
$ 682.1k
Gregory Hinckley
Independent Director15.2yrsUS$163.96k0.38%
$ 2.2m
Jeryl Hilleman
Independent Director6.3yrsUS$179.71k0.055%
$ 315.0k
John Freund
Independent Director13.2yrsUS$162.46k0.29%
$ 1.6m
Ralph Rashbaum
Member of Medical Advisory Board16.2yrsno datano data
Steven Garfin
Member of Medical Advisory Board16.2yrsno datano data
Frank Phillips
Member of Medical Advisory Board16.2yrsno datano data
A. Shamie
Member of Medical Advisory Board15.3yrsno datano data
Mika Nishimura
Independent Director5yrsUS$163.21k0.064%
$ 367.3k
Jonathan Hyde
Member of Surgeon Advisory Boardno datano datano data
15.3yrs
Average Tenure
68yo
Average Age

Experienced Board: SIBN's board of directors are seasoned and experienced ( 15.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/15 03:12
End of Day Share Price 2026/03/13 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

SI-BONE, Inc. is covered by 16 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Travis SteedBofA Global Research
Caitlin CroninCanaccord Genuity
Ross OsbornCantor Fitzgerald & Co.